Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab

<div>MRI before cessation of fingolimod in September 2016 (upper row) and 19 days after infusion of rituximab (July 2017; lower row). Coronal (<b>A/D </b>) and sagital (B/E) flair and coronal T2 (C/F) images show several new and enlarging lesions after switch to rituximab. Arrows indicate contrast enhancement on sagital T1 images (<b>D/G</b>).</div>

Case Reports in Neurological Medicine

fig1

Figure 1

Figure 1: Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab 